Pharmaceutical & Biotech
Artes Medical Hopes to Raise Eyebrows with Opening of Wrinkle Filler Plant in San Diego
Current dermal fillers, including Zyderm, Cosmoderm, Restlyane and Hylaform, are temporary, as they are absorbed and metabolized by a patient within a matter of months.
Released Thursday, March 10, 2005
Researched by Industrialinfo.com (Industrial Information Resources, Incorporated; Houston, Texas). Artes Medical Incorporated (San Diego, California) has just opened a 35,000 square foot cGMP manufacturing plant in San Diego. The privately-held specialty pharmaceutical and medical device company will use the new facility to manufacture ArteFill, a next generation product to Artecoll. Artecoll is an aesthetic medical product used to treat a wide variety of facial wrinkles and scars.
Current dermal fillers, including Zyderm, Cosmoderm, Restlyane and Hylaform, are temporary, as they are absorbed and metabolized by a patient within a matter of months. When ArteFill is injected, the microscopic spheres stimulate the body's own natural collagen production to replace the purified collagen, achieving lasting wrinkle correction. Final FDA approval is expected later this year, when Artes will launch the product in the United States.
There have been a number of recent news stories regarding the inappropriate use of these types of aesthetic products, administered by unlicensed individuals to groups of people in private homes. These treatments are especially dangerous to the consumer and possibly illegal. FDA-regulated aesthetic medical products are specifically designed to be administered by highly skilled and professionally trained physicians, such as plastic surgeons, cosmetic surgeons and dermatologists and are intended only for treatment in a professional medical setting.
Industrialinfo.com is the leading provider of global industrial market research. We specialize in helping companies develop information solutions to maximize their sales and marketing efforts.
View Plant Profile - 1065168
Industrialinfo.com is the leading provider of global industrial market research. We specialize in helping companies develop information solutions to maximize their sales and marketing efforts.
Want More IIR News Intelligence?
Make us a Preferred Source on Google to see more of us when you search.
Add Us On GoogleAsk Us
Have a question for our staff?
Submit a question and one of our experts will be happy to assist you.
Forecasts & Analytical Solutions
Where global project and asset data meets advanced analytics for smarter market sizing and forecasting.
Explore Our SolutionsRelated Articles
-
Eli Lilly Advances U.S. Manufacturing BuildoutSeptember 24, 2026
-
U.S. States Planning the Most Industrial Spending in 2027September 08, 2026
-
U.S. Megaprojects to Watch for in 2027September 01, 2026
-
GLP-1 Drugs Drive Pharma Construction WaveAugust 27, 2026
-
El Niño Shapes North America Fall, Winter OutlookAugust 27, 2026
PECWeb Global Market Intelligence Platform
Identify opportunities, anticipate change, and execute with confidence. PECWeb connects the industrial intelligence you need, from projects and assets to operational events, all in one platform.
Discover PecwebIndustry Intel
-
North America Refining 2026: New Pipelines to PADD 5Podcast Episode / Oct 2, 2026
-
Biomanufacturing Onshoring 2026: GLP-1 Drives CapexPodcast Episode / Oct 2, 2026
-
2026 US Data Center Outlook: Power, Land & CoolingPodcast Episode / Sep 18, 2026
-
2026 Global Power Demand Outlook: Gas, Nuclear & RenewablesPodcast Episode / Sep 18, 2026
-
2026 Oil & Gas CapEx Outlook: Middle East, LNG & PermianPodcast Episode / Sep 4, 2026